Mark Fuster

Title(s)Professor In Residence, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity
    NIH I01BX003688Oct 1, 2017 - Sep 30, 2021
    Role: Principal Investigator
    Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans
    NIH R01HL107652Jul 15, 2012 - May 31, 2017
    Role: Principal Investigator
    Glycosaminoglycans and Cell Traffic in the Lymphatic Microenvironment
    NIH I01BX000987Apr 1, 2011 - Mar 31, 2014
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Diversity of human salivary heparan sulfate. Glycobiology. 2024 Oct 03. Spliid CB, Mehta S, Fuster MM, Martino C, Morris CL, Lee N, Florentino I, Tong K, Liu L, Ackermann G, Knight R, Esko JD, De Mendoza TH. PMID: 39361890.
      View in: PubMed   Mentions:    Fields:    
    2. Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm. Front Oncol. 2024; 14:1417621. Fuster MM. PMID: 39165679; PMCID: PMC11333800.
      View in: PubMed   Mentions:
    3. Glycocalyx transduces membrane leak in brain tumor cells exposed to sharp magnetic pulsing. Biophys J. 2023 11 21; 122(22):4425-4439. Johns SC, Gupta P, Lee YH, Friend J, Fuster MM. PMID: 37992690; PMCID: PMC10698326.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. Time Domains of Hypoxia Responses and -Omics Insights. Front Physiol. 2022; 13:885295. Yu JJ, Non AL, Heinrich EC, Gu W, Alcock J, Moya EA, Lawrence ES, Tift MS, O'Brien KA, Storz JF, Signore AV, Khudyakov JI, Milsom WK, Wilson SM, Beall CM, Villafuerte FC, Stobdan T, Julian CG, Moore LG, Fuster MM, Stokes JA, Milner R, West JB, Zhang J, Shyy JY, Childebayeva A, Vázquez-Medina JP, Pham LV, Mesarwi OA, Hall JE, Cheviron ZA, Sieker J, Blood AB, Yuan JX, Scott GR, Rana BK, Ponganis PJ, Malhotra A, Powell FL, Simonson TS. PMID: 36035495; PMCID: PMC9400701.
      View in: PubMed   Mentions: 6  
    5. Genetic alteration of heparan sulfate in CD11c + immune cells inhibits inflammation and facilitates pathogen clearance during influenza A virus infection. Sci Rep. 2022 03 30; 12(1):5382. Kim SY, Gupta P, Johns SC, Zuniga EI, Teijaro JR, Fuster MM. PMID: 35354833; PMCID: PMC8968721.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    6. IL-33/ST2 receptor-dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice. Physiol Rep. 2022 02; 10(3):e15185. Indralingam CS, Gutierrez-Gonzalez AK, Johns SC, Tsui T, Cannon DT, Fuster MM, Bigby TD, Jennings PA, Breen EC. PMID: 35150208; PMCID: PMC8839421.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    7. Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia. Neoplasia. 2021 11; 23(11):1137-1143. Kim SY, Johns SC, Gupta P, Varki N, Fuster MM. PMID: 34715561; PMCID: PMC8560828.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    8. Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma. Cancers (Basel). 2021 Aug 23; 13(16). Tsai JC, Saad OA, Magesh S, Xu J, Lee AC, Li WT, Chakladar J, Fuster MM, Chang EY, Wang-Rodriguez J, Ongkeko WM. PMID: 34439379; PMCID: PMC8391195.
      View in: PubMed   Mentions: 2  
    9. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Antiviral Res. 2020 09; 181:104873. Kim SY, Jin W, Sood A, Montgomery DW, Grant OC, Fuster MM, Fu L, Dordick JS, Woods RJ, Zhang F, Linhardt RJ. PMID: 32653452; PMCID: PMC7347485.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansCellsPHPublic Health
    10. A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment. Am J Phys Med Rehabil. 2020 03; 99(3):233-240. Ha D, Kerr J, Ries AL, Fuster MM, Lippman SM, Murphy JD. PMID: 31361623; PMCID: PMC6982544.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Pulsed Low-Frequency Magnetic Fields Induce Tumor Membrane Disruption and Altered Cell Viability. Biophys J. 2020 04 07; 118(7):1552-1563. Ashdown CP, Johns SC, Aminov E, Unanian M, Connacher W, Friend J, Fuster MM. PMID: 32142642; PMCID: PMC7136334.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    12. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer. 2020 Oct; 28(10):4707-4720. Ha D, Ries AL, Lippman SM, Fuster MM. PMID: 31965306; PMCID: PMC7371511.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Functional Cellular Anti-Tumor Mechanisms are Augmented by Genetic Proteoglycan Targeting. Neoplasia. 2020 02; 22(2):86-97. Gupta P, Johns SC, Kim SY, El Ghazal R, Zuniga EI, Fuster MM. PMID: 31896526; PMCID: PMC6940629.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    14. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362. Burks AC, Gould MK, Silvestri G, Yarmus LB, Sears CR, Arenberg DA, Gonzalez AV, Slatore CG, Tanner NT, Vachani A, Nana-Sinkam P, Fuster MM, Wahidi MM, Tanoue LT, Rivera MP. PMID: 31437410.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure. Respir Physiol Neurobiol. 2019 11; 269:103264. Ha D, Malhotra A, Ries AL, O'Neal WT, Fuster MM. PMID: 31376471; PMCID: PMC6759398.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med. 2018 08; 141:172-179. Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. PMID: 30053964; PMCID: PMC6104385.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Jul; 26(7):2459-2469. Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. PMID: 29429006; PMCID: PMC6110278.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    18. Ventilator-induced lung injury increases expression of endothelial inflammatory mediators in the kidney. Am J Physiol Renal Physiol. 2017 04 01; 312(4):F654-F660. Hepokoski M, Englert JA, Baron RM, Crotty-Alexander LE, Fuster MM, Beitler JR, Malhotra A, Singh P. PMID: 28365585; PMCID: PMC5407070.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    19. Advances in lung cancer with a focus on ATS 2016 updates. J Thorac Dis. 2016 Jul; 8(Suppl 7):S566-8. Li J, Fuster MM. PMID: 27606096; PMCID: PMC4990685.
      View in: PubMed   Mentions:
    20. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis. Circ Res. 2016 07 08; 119(2):210-21. Johns SC, Yin X, Jeltsch M, Bishop JR, Schuksz M, El Ghazal R, Wilcox-Adelman SA, Alitalo K, Fuster MM. PMID: 27225479; PMCID: PMC4938725.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    21. The Utility of Exercise Testing in Patients with Lung Cancer. J Thorac Oncol. 2016 09; 11(9):1397-410. Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M. PMID: 27156441; PMCID: PMC5483326.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    22. Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth. Neoplasia. 2016 05; 18(5):294-306. El Ghazal R, Yin X, Johns SC, Swanson L, Macal M, Ghosh P, Zuniga EI, Fuster MM. PMID: 27237321; PMCID: PMC4887599.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    23. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions. J Biol Chem. 2016 Jun 10; 291(24):12627-12640. Dyer DP, Salanga CL, Johns SC, Valdambrini E, Fuster MM, Milner CM, Day AJ, Handel TM. PMID: 27044744; PMCID: PMC4933465.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    24. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015 Dec; 35 Suppl:S276-S304. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. PMID: 26590477; PMCID: PMC4819002.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    25. Examining Roles of Glycans in Chemokine-Mediated Dendritic-Endothelial Cell Interactions. Methods Enzymol. 2016; 570:335-55. Yin X, Johns SC, El Ghazal R, Salanga CL, Handel TM, Fuster MM. PMID: 26921954.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    26. Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk. Ann Thorac Surg. 2015 Nov; 100(5):1954-62. Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ. PMID: 26410158; PMCID: PMC7286063.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. The Need for More E-Cigarette Data: A Call to Action. Am J Respir Crit Care Med. 2015 Aug 01; 192(3):275-6. Crotty Alexander L, Fuster M, Montgrain P, Malhotra A. PMID: 26230232.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    28. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015 Dec; 35 Suppl:S224-S243. Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. PMID: 25600295; PMCID: PMC4737670.
      View in: PubMed   Mentions: 205     Fields:    Translation:Humans
    29. Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node. J Immunol. 2014 Mar 01; 192(5):2133-42. Yin X, Johns SC, Kim D, Mikulski Z, Salanga CL, Handel TM, Macal M, Zúñiga EI, Fuster MM. PMID: 24493818; PMCID: PMC3960083.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    30. A general method for site specific fluorescent labeling of recombinant chemokines. PLoS One. 2014; 9(1):e81454. Kawamura T, Stephens B, Qin L, Yin X, Dores MR, Smith TH, Grimsey N, Abagyan R, Trejo J, Kufareva I, Fuster MM, Salanga CL, Handel TM. PMID: 24489642; PMCID: PMC3904831.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    31. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Ther Adv Respir Dis. 2014 Feb; 8(1):3-12. Haidar YM, Rahn DA, Nath S, Song W, Bazhenova L, Makani S, Fuster MM, Sandhu AP. PMID: 24334338.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    32. Stereotactic body radiation therapy in octogenarians with stage I lung cancer. Clin Lung Cancer. 2014 Mar; 15(2):131-5. Sandhu AP, Lau SK, Rahn D, Nath SK, Kim D, Song WY, Gulaya S, Fuster MM, Bazhenova L, Mundt AJ. PMID: 24157245.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases. J Radiosurg SBRT. 2012; 1(4):317-325. Kim D, Fuster MM, Nath SK, Bharne A, Read W, Bazhenova L, Song WY, Mundt AJ, Sandhu AP. PMID: 29296332; PMCID: PMC5658866.
      View in: PubMed   Mentions:
    34. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases. J Radiosurg SBRT. 2012; 2(1):63-72. Kim D, Fuster MM, Nath SK, Bharne A, Read W, Bazhenova L, Song WY, Mundt AJ, Sandhu AP. PMID: 29296343; PMCID: PMC5658854.
      View in: PubMed   Mentions:
    35. Hypofractionated radiotherapy as definitive treatment of stage I non-small cell lung cancer in older patients. Am J Clin Oncol. 2011 Jun; 34(3):254-8. Ahmad E, Sandhu AP, Fuster MM, Messer K, Pu M, Nobiensky P, Bazhenova L, Seagren S. PMID: 20562588.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    36. Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/ computed tomography. Clin Lung Cancer. 2011 May; 12(3):180-6. Nath SK, Sandhu AP, Jensen L, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster MM, Bazhenova L, Song WY, Mundt AJ. PMID: 21663861.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol. 2011 Apr; 99(1):12-7. Nath SK, Sandhu AP, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster M, Bazhenova L, Song WY, Mundt AJ. PMID: 21429608.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    38. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C). J Biol Chem. 2011 Apr 29; 286(17):14952-62. Yin X, Johns SC, Lawrence R, Xu D, Reddi K, Bishop JR, Varner JA, Fuster MM. PMID: 21343305; PMCID: PMC3083229.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    39. A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis. Mol Cancer. 2010 Dec 20; 9:316. Yin X, Truty J, Lawrence R, Johns SC, Srinivasan RS, Handel TM, Fuster MM. PMID: 21172016; PMCID: PMC3019167.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    40. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem. 2011 Jan 07; 286(1):737-45. Xu D, Fuster MM, Lawrence R, Esko JD. PMID: 20974861; PMCID: PMC3013032.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    41. Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci. 2010; 93:179-212. Fuster MM, Wang L. PMID: 20807646; PMCID: PMC3703633.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimals
    42. Definitive radiation therapy for stage I non-small-cell lung carcinoma: institutional experience with contemporary conformal planning. Clin Lung Cancer. 2009 Nov; 10(6):433-7. Sandhu AP, Messer K, Fuster MM, Ahmad E, Pu M, Bazhenova L, Rose M, Seagren S. PMID: 19900862.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    43. Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation. J Immunol. 2009 Sep 15; 183(6):3971-9. Zuberi RI, Ge XN, Jiang S, Bahaie NS, Kang BN, Hosseinkhani RM, Frenzel EM, Fuster MM, Esko JD, Rao SP, Sriramarao P. PMID: 19710461; PMCID: PMC2872128.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    44. Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13075-80. Schuksz M, Fuster MM, Brown JR, Crawford BE, Ditto DP, Lawrence R, Glass CA, Wang L, Tor Y, Esko JD. PMID: 18725627; PMCID: PMC2529023.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimalsCells
    45. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol. 2007 May 07; 177(3):539-49. Fuster MM, Wang L, Castagnola J, Sikora L, Reddi K, Lee PH, Radek KA, Schuksz M, Bishop JR, Gallo RL, Sriramarao P, Esko JD. PMID: 17470635; PMCID: PMC2064806.
      View in: PubMed   Mentions: 62     Fields:    Translation:AnimalsCells
    46. Methods to study lymphatic vessel integrins. Methods Enzymol. 2007; 426:415-38. Garmy-Susini B, Makale M, Fuster M, Varner JA. PMID: 17697894.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    47. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin Cancer Res. 2006 May 01; 12(9):2894-901. Brown JR, Fuster MM, Li R, Varki N, Glass CA, Esko JD. PMID: 16675586.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    48. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol. 2005 Sep; 6(9):902-10. Wang L, Fuster M, Sriramarao P, Esko JD. PMID: 16056228.
      View in: PubMed   Mentions: 225     Fields:    Translation:AnimalsCells
    49. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005 Jul; 5(7):526-42. Fuster MM, Esko JD. PMID: 16069816.
      View in: PubMed   Mentions: 567     Fields:    Translation:Humans
    50. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 2003 Jun 01; 63(11):2775-81. Fuster MM, Brown JR, Wang L, Esko JD. PMID: 12782582.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    51. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem. 2003 Jun 27; 278(26):23352-9. Brown JR, Fuster MM, Whisenant T, Esko JD. PMID: 12686549.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    52. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):371-6. Belting M, Borsig L, Fuster MM, Brown JR, Persson L, Fransson LA, Esko JD. PMID: 11752393; PMCID: PMC117567.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    Mark's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (52)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California